News & Updates

Corticosteroids lessen mechanical ventilation use in CAP
Corticosteroids lessen mechanical ventilation use in CAP
03 Jan 2025 byStephen Padilla

In critically ill patients with community-acquired pneumonia (CAP), treatment with corticosteroids has significantly reduced the need for mechanical ventilation, while use of hydrocortisone has prevented many hospital deaths.

Corticosteroids lessen mechanical ventilation use in CAP
03 Jan 2025
Ipilimumab plus nivolumab elicits response in mCRPC
Ipilimumab plus nivolumab elicits response in mCRPC
02 Jan 2025 byStephen Padilla

Use of dual immune checkpoint inhibitors (ICIs), nivolumab and ipilimumab, exhibits responses in some molecularly selected patients with metastatic castration-resistant prostate cancer (mCRPC), including those with mismatch repair deficiency (dMMR), nonsynonymous tumour mutational burden ≥7.1 muts/Mb (hTMB), a BRCA2 mutation (BRCAm), or biallelic CDK12 inactivation (CDK12i).

Ipilimumab plus nivolumab elicits response in mCRPC
02 Jan 2025
NT-proBNP predicts cardiorenal complications in Chinese patients with T2D
NT-proBNP predicts cardiorenal complications in Chinese patients with T2D
30 Dec 2024 byChristina Lau

Elevated N-terminal pro–B-type natriuretic peptide (NT-proBNP) levels independently predict cardiorenal complications in Chinese patients with type 2 diabetes (T2D) and can be utilized as a clinical prognostic biomarker for risk stratification to enable more intensive organ-protective treatment in those at risk, a study involving 1,993 patients enrolled in the Hong Kong Diabetes Biobank has shown.

NT-proBNP predicts cardiorenal complications in Chinese patients with T2D
30 Dec 2024